About this trial
The goal of this observational study is to learn about the comorbidity patterns of interstitial and airway abnormalities in adults undergoing health examinations in China. The main questions it aims to answer are:
How do early interstitial lung abnormalities progress to comorbid interstitial and airway diseases? What are the key factors associated with this progression?
Participants undergoing routine health examinations will be assessed for interstitial and airway abnormalities based on imaging and clinical data. Longitudinal follow-up will be used to evaluate disease progression and identify associated risk factors.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Underwent chest CT examination between January 1, 2017 and December 31, 2024
Age 18 years or older at the time of examination
Disqualifiers
None
Trial population
Participants were recruited from multiple health checkup centers across various regions of China between 2017 and 2024. Specifically, this retrospective study included data from 10 hospital-based health examination institutions located within the four major economic regions of China (East, Central, West, and Northeast). All available health examination records of individuals who underwent chest CT scans during this period were collected for analysis.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
high-resolution computed tomography (HRCT) examinations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: